Attributions enregistrées du 17 févr. 2026 au 7 mai 2026
Principaux fournisseurs parmi les 500 dernières attributions
Catégories de 33 contrats classés
| Contrat | Fournisseur | Valeur | Date d’attribution |
|---|---|---|---|
| Multiple Award Schedule | TENT COMPANY OF NORFOLK LLC | USD 1,000,000 | 7 mai 2026 |
| Multiple Award Schedule | OVERLOOK SYSTEMS TECHNOLOGIES, INC. | USD 12,000,000 | 28 avr. 2026 |
| Multiple Award Schedule | SELLMARK CORPORATION | USD 475,000 | 20 avr. 2026 |
| Multiple Award Schedule | CHEROKEE NATION INTEGRATED HEALTH, L.L.C. | USD 3,490,000 | 17 avr. 2026 |
| Multiple Award Schedule | ValorTech.AI LLC | USD 475,000 | 30 mars 2026 |
| Multiple Award Schedule | KV CONSULTING LLC | USD 1,000,000 | 24 mars 2026 |
| Multiple Award Schedule | REKOR RECOGNITION SYSTEMS, INC. | USD 500,000 | 20 mars 2026 |
| Multiple Award Schedule | UNIQSOFT INC | USD 475,000 | 20 mars 2026 |
| Multiple Award Schedule | PROSOURCE PACKAGING INC | USD 20,000,000 | 20 mars 2026 |
| Multiple Award Schedule | US COMMUNICATIONS & ELECTRIC INC | USD 3,000,000 | 20 mars 2026 |
| Multiple Award Schedule | BRIGHT STAR SOLUTIONS LLC | USD 1,000,000 | 19 mars 2026 |
| Multiple Award Schedule | HARMONIC SOLUTIONS LLC | USD 10,000,000 | 18 mars 2026 |
| Multiple Award Schedule | B2 CONSTRUCTORS, LLC | USD 500,000 | 11 mars 2026 |
| Multiple Award Schedule | RANK ONE COMPUTING CORPORATION | USD 500,000 | 11 mars 2026 |
| Multiple Award Schedule | NEXT STEP GROUP INC | USD 475,000 | 10 mars 2026 |
| Multiple Award Schedule | BLINKLY, INC. | USD 950,000 | 10 mars 2026 |
| Multiple Award Schedule | THE UNITED STATES PHARMACOPEIAL CONVENTION, INC. | USD 1,000,000 | 9 mars 2026 |
| Multiple Award Schedule | FORTIS NATIVE GROUP LLC | USD 5,400,000 | 8 mars 2026 |
| Multiple Award Schedule | TOR ENGINEERING CORPORATION | USD 500,000 | 4 mars 2026 |
| Multiple Award Schedule | EVOLVEX LLC | USD 500,000 | 4 mars 2026 |
« Non divulguée » signifie que l’acheteur n’a publié aucun montant. Les valeurs sont affichées dans la devise de l’avis.